EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Expanding the scope of the infectious diseases pharmacist in HCT: Beyond antimicrobial stewardship

Heather Weerdenburg, Julian Lindsay

Transplant Infectious Disease · 2023

DOI: 10.1111/tid.14094 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Transplant Infectious Disease, 2023. Verfasst von Heather Weerdenburg und 1 weiteren Autor:innen. Beteiligte Einrichtung: Children's Cancer Centre, Royal Children's Hospital, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Antimicrobial Stewardship, Hematopoietic Stem Cell Transplantation, Communicable Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Infectious disease (ID) pharmacists and antimicrobial stewardship (AMS) programs are integral to the infection management of hematopoietic cell transplant (HCT) recipients demonstrating effective implementation of clinical pathways, de‐escalation of empirical antibiotics for febrile neutropenia (FN), allergy assessments, and use of rapid diagnostic testing. The HCT procedure is complex, dynamic, and a high risk for infectious complications. Therefore, there is an important role for an ID and AMS pharmacist to collaborate with the primary treating team, with ongoing care, involving the optimal individual patient prophylactic, pre‐emptive and treatment management of infections in this high‐risk population.

Conclusion

This review highlights key factors for consideration of ID/AMS Pharmacists in relation to HCT, including important aspects in the evaluation of infection risk prior to transplant, risk from donor sources, length of, and changes in immunosuppression, and potential drug‐drug interactions from other essential supportive care therapies. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antimicrobial StewardshipHematopoietic Stem Cell TransplantationCommunicable DiseasesHumansPharmacistsAnti-Bacterial Agents

Stichwörter der Autor:innen

antimicrobialhematopoietic cell transplantinfectionspharmacist

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Children's Cancer Centre, Royal Children's Hospital, Melbourne, Victoria, Australia.
  • Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia.
  • Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
  • Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • National Centre for Infections in Cancer and Transplantation (NCICT), Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Zitieren

APA

Weerdenburg, H., & Lindsay, J. (2023). Expanding the scope of the infectious diseases pharmacist in HCT: Beyond antimicrobial stewardship. Transplant Infectious Disease. https://doi.org/10.1111/tid.14094

Vancouver

Weerdenburg H, Lindsay J. Expanding the scope of the infectious diseases pharmacist in HCT: Beyond antimicrobial stewardship. Transplant Infectious Disease. 2023. doi:10.1111/tid.14094

BibTeX
@article{Weerdenburg2023,
  author = {Weerdenburg, Heather and Lindsay, Julian},
  title = {Expanding the scope of the infectious diseases pharmacist in HCT: Beyond antimicrobial stewardship},
  journal = {Transplant Infectious Disease},
  year = {2023},
  doi = {10.1111/tid.14094}
}
Kostenlos starten →